Piramal Healthcare to buy Minrad for $40 mn

24 Dec 2008

Pharma Company Piramal Healthcare Ltd has signed a deal to buy US based inhalation anaesthetics maker Minrad International Inc for about US $40 million in cash and debt. Under the terms, Minrad shareholders will get 12 cents a share in cash, a 100% premium to the stock’s on Monday closing price on the American Stock Exchange (Amex). Piramal will also buy Minrad’s senior secured convertible notes.

 

The offer to Minrad is consistent with its commitment to build a serious global presence in critical care. With this acquisition, Piramal will gain access to the intellectual property for making inhalation anaesthetics and will be able to immediately break into the US pharmaceutical market for the country’s top-selling inhalation anaesthetic, sevoflurane. The deal is expected to close in the first quarter of 2009 subject to Minrad shareholders approval and will add to Piramal’s earnings for the year to March 2010.

 

This year, the company has already acquired German PlasmaSelect AG’s blood expansion products, two brands from the India-based Khandelwal Labs, and bought out Bangalore-based Healthline Pvt Ltd’s drug business.crackcrack
Related Piramal Enterprises Ltd. Links:

Piramal Enterprises Share Price

1956.90 -35.80 (-1.80%) Mar 04, 18:59
1 Year Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 618.65
Dr. Reddys Lab 4574.30
Lupin 1048.15
Piramal Enterprises 1956.90
Cadila Healthcare 449.00
View more..
Sensex vs Piramal Enterprises
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback